CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Azelastine HCl and fluticasone propionate

Last Updated: December 9, 2014
Result type: Reports
Project Number: SR0408-000
Product Line: Reimbursement Review

Generic Name: Azelastine HCl and fluticasone propionate

Brand Name: Dymista

Manufacturer: Meda Pharmaceuticals Ltd.

Therapeutic Area: Seasonal allergic rhinitis

Indications: Seasonal allergic rhinitis

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: June 17, 2015

Recommendation Type: Do not list